Scientists are working hard to find better ways to treat Parkinson’s disease, a condition that slowly damages the brain and affects movement, thinking, and daily life.
A new study from Stanford Medicine has brought fresh hope. The researchers found that turning off a specific enzyme in the brain may help protect brain cells and possibly slow down or even stop the disease from getting worse.
Parkinson’s disease happens when certain brain cells, especially those that produce dopamine, begin to die. Dopamine is a chemical that helps control movement, motivation, and decision-making.
When these cells are lost, people may develop symptoms such as shaking, stiffness, slow movement, and balance problems. However, these symptoms often appear many years after the disease has already started.
In some people, Parkinson’s disease is linked to a genetic mutation. This mutation affects an enzyme called LRRK2. Enzymes are proteins in the body that help control many important processes. In this case, the LRRK2 enzyme becomes too active. When it is overactive, it disrupts how brain cells communicate with each other, which can lead to damage over time.
The research team, led by Dr. Suzanne Pfeffer, focused on how this overactive enzyme affects communication in the brain. They looked closely at a region called the striatum, which plays an important role in movement and behavior. In a healthy brain, dopamine-producing neurons send signals to other cells in this area, helping the brain work smoothly.
The scientists discovered that when LRRK2 is too active, it damages tiny structures on cells called primary cilia. These structures are like small antennas that help cells receive signals from their environment. Without these cilia, the cells cannot “hear” important messages from other parts of the brain.
One key signal is known as the “sonic hedgehog” signal. Despite its unusual name, this signal is very important. It tells support cells in the brain to release protective proteins that help keep neurons alive, especially during stress.
When cells lose their cilia, they cannot respond to this signal. As a result, they stop producing these protective proteins, and nearby neurons become more vulnerable to damage.
To test a possible solution, the researchers used a molecule called MLi-2, which can block the activity of the LRRK2 enzyme. They gave this treatment to mice that carried the genetic mutation. At first, they tried a short treatment of two weeks, but it did not show clear results.
Instead of giving up, the team decided to continue the treatment for a longer time. They extended it to three months. This decision was based on earlier research suggesting that cells that do not divide can slowly regrow their cilia if given enough time.
The longer treatment made a big difference. The tiny cilia on the cells began to grow back. Once these structures returned, the cells could again receive signals properly. The “sonic hedgehog” communication pathway was restored, and the support cells started producing protective proteins again.
As a result, the stress on dopamine-producing neurons decreased. The researchers also found signs that damaged neurons were beginning to recover, which is especially exciting. This suggests that the treatment may not only slow down damage but could also help repair some of the harm already done.
Dr. Pfeffer explained that this discovery could be very important for people who carry the LRRK2 mutation. Early signs of Parkinson’s disease, such as loss of smell, sleep problems, and digestive issues, can appear many years before the more visible symptoms like tremors. If people at risk could be identified early, treatment might begin before serious damage occurs.
The study also raises hope for a wider group of patients. Although this research focused on a specific genetic form of Parkinson’s disease, the scientists believe the same approach might help in other forms of the condition. There are already several clinical trials testing drugs that block the LRRK2 enzyme in humans.
This study shows that understanding how brain cells communicate is key to finding better treatments. By fixing the communication system, scientists may be able to protect brain cells and improve brain function.
The research was a collaboration with scientists in Scotland and was funded by organizations including The Michael J. Fox Foundation, the Aligning Science Across Parkinson’s initiative, and the UK Medical Research Council. It was published in the journal Science Signaling.
While more research is needed before this treatment can be widely used, the findings offer real hope. They suggest that future treatments might not only slow Parkinson’s disease but also help restore the health of the brain.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2026 Knowridge Science Report. All rights reserved.
